Item 8.01 Other Events.
On January 6, 2021, Selecta Biosciences, Inc. (the "Company") issued a press
release providing details of results from preclinical activities involving
co-administration of AAV8 and the Company's ImmTOR technology in non-human
primates. A copy of the above referenced press release is filed as Exhibit 99.1
to this Current Report on Form 8-K.
Item 9.01. Financial Statements and Exhibits.
(d) Exhibits
Exhibit
No. Description
99.1 Press Release of the Company dated January 6, 2021
--------------------------------------------------------------------------------
© Edgar Online, source Glimpses